Tolerability of Ramipril 10 mg Daily in High-risk Cardiovascular Patients in Taiwan: Experience from Kaohsiung Medical University Chung-Ho Memorial Hospital

Tolerability of Ramipril 10 mg Daily in High-risk Cardiovascular Patients in Taiwan: Experience from Kaohsiung Medical University Chung-Ho Memorial Hospital

The Heart Outcomes Prevention Evaluation (HOPE) study demonstrated that the angiotensin-converting enzyme inhibitor, ramipril, significantly reduces mortality, myocardial infarction and stroke in high-risk cardiovascular patients, beyond the benefits from blood pressure lowering. The tolerability of...

Full description

Bibliographic Details
Main Authors: Chih-Sheng Chu, Kai-Hung Cheng, Kun-Tai Lee, Tsung-Hsien Lin, Shuo-Tsan Lee, Ho-Ming Su, Wen-Choi Voon, Sheng-Hsiung Sheu, Wen-Ter Lai
Format: Article
Language:English
Published: Wiley 2005-11-01
Series:Kaohsiung Journal of Medical Sciences
Subjects:
ACE inhibitor
adverse effect
tolerability
Online Access:http://www.sciencedirect.com/science/article/pii/S1607551X09701597

Internet

http://www.sciencedirect.com/science/article/pii/S1607551X09701597

Similar Items